147 related articles for article (PubMed ID: 21928309)
1. High-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: validation of a technique.
Fan X; Haney CR; Agrawal G; Pelizzari CA; Antic T; Eggener SE; Sethi I; River JN; Zamora M; Karczmar GS; Oto A
J Magn Reson Imaging; 2011 Oct; 34(4):956-61. PubMed ID: 21928309
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection.
Morgan VA; Kyriazi S; Ashley SE; DeSouza NM
Acta Radiol; 2007 Jul; 48(6):695-703. PubMed ID: 17611881
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
[TBL] [Abstract][Full Text] [Related]
5. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
Gibbs P; Liney GP; Pickles MD; Zelhof B; Rodrigues G; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):572-6. PubMed ID: 19692841
[TBL] [Abstract][Full Text] [Related]
6. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI.
Madabhushi A; Feldman MD; Metaxas DN; Tomaszeweski J; Chute D
IEEE Trans Med Imaging; 2005 Dec; 24(12):1611-25. PubMed ID: 16350920
[TBL] [Abstract][Full Text] [Related]
7. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features.
Langer DL; van der Kwast TH; Evans AJ; Plotkin A; Trachtenberg J; Wilson BC; Haider MA
Radiology; 2010 May; 255(2):485-94. PubMed ID: 20413761
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
[TBL] [Abstract][Full Text] [Related]
9. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
[TBL] [Abstract][Full Text] [Related]
10. Principal component analysis of dynamic contrast enhanced MRI in human prostate cancer.
Eyal E; Bloch BN; Rofsky NM; Furman-Haran E; Genega EM; Lenkinski RE; Degani H
Invest Radiol; 2010 Apr; 45(4):174-81. PubMed ID: 20177391
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging.
Miao H; Fukatsu H; Ishigaki T
Eur J Radiol; 2007 Feb; 61(2):297-302. PubMed ID: 17085002
[TBL] [Abstract][Full Text] [Related]
12. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.
Kim JH; Kim JK; Park BW; Kim N; Cho KS
J Magn Reson Imaging; 2008 Nov; 28(5):1173-9. PubMed ID: 18837000
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
[TBL] [Abstract][Full Text] [Related]
15. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer.
Zelhof B; Pickles M; Liney G; Gibbs P; Rodrigues G; Kraus S; Turnbull L
BJU Int; 2009 Apr; 103(7):883-8. PubMed ID: 19007373
[TBL] [Abstract][Full Text] [Related]
16. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
17. Value of multiparametric prostate MRI of the peripheral zone.
Weidner AM; Michaely HJ; Lemke A; Breitinger L; Wenz F; Marx A; Schoenberg SO; Dinter DJ
Z Med Phys; 2011 Sep; 21(3):198-205. PubMed ID: 21247742
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
Kitajima K; Kaji Y; Fukabori Y; Yoshida K; Suganuma N; Sugimura K
J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate.
Hansford BG; Karademir I; Peng Y; Jiang Y; Karczmar G; Thomas S; Yousuf A; Antic T; Eggener S; Oto A
Acad Radiol; 2014 May; 21(5):569-77. PubMed ID: 24703469
[TBL] [Abstract][Full Text] [Related]
20. [MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging].
Beyersdorff D; Darsow U; Stephan C; Schnorr D; Loening S; Taupitz M
Rofo; 2003 Jun; 175(6):799-805. PubMed ID: 12811693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]